SP100 exhibited context-dependent roles: high expression correlated with better prognosis in breast/lung cancers but poorer outcomes in glioma/PAAD, while low expression in LSCC was linked to tumorigenesis. The gene discussed is SP100; the disease is central nervous system cancer.